Postpartum hypertension gene and aging study
Part of Heart & circulation, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at two things in women with postpartum hypertension (high blood pressure after giving birth). It tests a gene called Renalase and measures the length of telomeres (a marker of cell aging) to see if they are linked to this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with high blood pressure after giving birth
- You do not have other medical conditions like sickle cell disease, heart disease, kidney disease, or connective tissue disorders
- Your blood pressure readings were not taken during a surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who had high blood pressure during pregnancy and/or in the first two weeks after delivery. The goal is to better understand postpartum hypertension so care can be improved for mothers at higher risk.
This early study looks at how “angiotensin II” receptors behave in women after preeclampsia compared with women who didn’t have it. It may help researchers understand long-term health risks after pregnancy and guide future treatments.
This study looks at people with preeclampsia during pregnancy and how their lung blood pressure and related symptoms change after delivery. It may help doctors better monitor and manage postpartum risks, especially involving the heart and lungs.
This study looks at how your genes affect your blood pressure and response to treatment. It may help find better ways to manage high blood pressure.
This trial follows women who have had preeclampsia to learn more about their health after pregnancy. It collects blood and tissue samples to find markers that could improve future care.
This study looks at heart and metabolic health during late pregnancy and after delivery, tracking both healthy women and those with complications like high blood pressure or diabetes in pregnancy. The goal is to understand how these risks change and what can be done to improve long-term health.
Hear when a new Renalase(rs10887800) Genotyping & Leucocytes Telomere Length in Patients With Postpartum Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.